Chris Jensen Health & Rehabilitation Center in Duluth, MN

Chris Jensen Health & Rehabilitation Center is a medicare and medicaid certified nursing home in Duluth, Minnesota. It is located in St. Louis county at 2501 Rice Lake Road, Duluth, Minnesota 55811. You can reach out to the office of Chris Jensen Health & Rehabilitation Center via phone at (218) 625-6400. This skilled nursing facility has 170 federally certified beds with average occupancy rate of 60.59%. Its legal business name is Chris Jensen Llc and has the following ownership type - For Profit - Corporation.

Chris Jensen Health & Rehabilitation Center (Medicare CCN 245366) is certified by CMS (Centers for Medicare & Medicaid Services) and participates in both medicare and medicaid program. This means if you are part of medicare or medicaid program, you may consider this nursing facility for your medical needs. It was first certified by CMS in 1986 (38 years certified) and the last quality survey was conducted in September, 2019.

Contact Information

Chris Jensen Health & Rehabilitation Center
2501 Rice Lake Road, Duluth, Minnesota 55811
(218) 625-6400


Nursing Home Profile

NameChris Jensen Health & Rehabilitation Center
Location2501 Rice Lake Road, Duluth, Minnesota
Certified ByMedicare and Medicaid
No. of Certified Beds170
Occupancy Rate60.59%
Medicare ID (CCN)245366
Legal Business NameChris Jensen Llc
Ownership TypeFor Profit - Corporation

NPI Associated with this Nursing Home:

Nursing Homes may have multiple NPI numbers. We have found possible NPI number/s associated with Chris Jensen Health & Rehabilitation Center from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number1104165711
Organization NameGENESIS REHAB SERVICES
Address2501 Rice Lake Rd, Duluth, MN 55811
Phone Number218-625-6400

News Archive

FDA approves BENLYSTA for active, autoantibody-positive systemic lupus erythematosus

Human Genome Sciences, Inc. and GlaxoSmithKline PLC today announced that the U.S. Food and Drug Administration has approved BENLYSTA® (belimumab) for the treatment of adult patients with active, autoantibody-positive systemic lupus erythematosus (SLE) who are receiving standard therapy.

Phase II study of TroVax vaccine in patients with metastatic colorectal cancer

A therapeutic cancer vaccine has shown effectiveness when given alongside chemotherapy to patients with metastatic colorectal cancer in a phase II trial, according to researchers at Oxford BioMedica (UK) Ltd.

Severely obese children have lipoprotein profiles that signal early risk of cardiovascular disease and the metabolic syndrome

"The message is urgent about the importance of prevention of cardiovascular disease in childhood. Lifestyle modification with appropriate diet and exercise can reduce cardiovascular risk in children," said lead author Daniel L. Preud'Homme, M.D., associate professor of medicine at the Wright State University School of Medicine and director of the lipid clinic at The Children's Medical Center, both in Dayton, Ohio.

RMND1 gene mutations responsible for severe neurodegenerative disorders

Scientists at the Montreal Neurological Institute and Hospital - The Neuro, McGill University working with a team at Oxford University have uncovered the genetic defect underlying a group of rare genetic disorders.

Latin America attempts to increase access to emergency contraception

Governments across Latin America are attempting to increase access to emergency contraception - which can prevent pregnancy if taken within 72 hours of sexual intercourse - despite "stiff resistance" from the Roman Catholic Church, Reuters reports.

Read more Medical News

› Verified 9 days ago


NPI Number1205174968
Organization NameCHRIS JENSEN
Address2501 Rice Lake Rd, Duluth, MN 55811
Phone Number218-625-6444

News Archive

FDA approves BENLYSTA for active, autoantibody-positive systemic lupus erythematosus

Human Genome Sciences, Inc. and GlaxoSmithKline PLC today announced that the U.S. Food and Drug Administration has approved BENLYSTA® (belimumab) for the treatment of adult patients with active, autoantibody-positive systemic lupus erythematosus (SLE) who are receiving standard therapy.

Phase II study of TroVax vaccine in patients with metastatic colorectal cancer

A therapeutic cancer vaccine has shown effectiveness when given alongside chemotherapy to patients with metastatic colorectal cancer in a phase II trial, according to researchers at Oxford BioMedica (UK) Ltd.

Severely obese children have lipoprotein profiles that signal early risk of cardiovascular disease and the metabolic syndrome

"The message is urgent about the importance of prevention of cardiovascular disease in childhood. Lifestyle modification with appropriate diet and exercise can reduce cardiovascular risk in children," said lead author Daniel L. Preud'Homme, M.D., associate professor of medicine at the Wright State University School of Medicine and director of the lipid clinic at The Children's Medical Center, both in Dayton, Ohio.

RMND1 gene mutations responsible for severe neurodegenerative disorders

Scientists at the Montreal Neurological Institute and Hospital - The Neuro, McGill University working with a team at Oxford University have uncovered the genetic defect underlying a group of rare genetic disorders.

Latin America attempts to increase access to emergency contraception

Governments across Latin America are attempting to increase access to emergency contraception - which can prevent pregnancy if taken within 72 hours of sexual intercourse - despite "stiff resistance" from the Roman Catholic Church, Reuters reports.

Read more Medical News

› Verified 9 days ago


NPI Number1215275235
Organization NameCHRIS JENSEN HEALTH & REHAB
Address2501 Rice Lake Rd, Duluth, MN 55811
Phone Number218-625-6440

News Archive

FDA approves BENLYSTA for active, autoantibody-positive systemic lupus erythematosus

Human Genome Sciences, Inc. and GlaxoSmithKline PLC today announced that the U.S. Food and Drug Administration has approved BENLYSTA® (belimumab) for the treatment of adult patients with active, autoantibody-positive systemic lupus erythematosus (SLE) who are receiving standard therapy.

Phase II study of TroVax vaccine in patients with metastatic colorectal cancer

A therapeutic cancer vaccine has shown effectiveness when given alongside chemotherapy to patients with metastatic colorectal cancer in a phase II trial, according to researchers at Oxford BioMedica (UK) Ltd.

Severely obese children have lipoprotein profiles that signal early risk of cardiovascular disease and the metabolic syndrome

"The message is urgent about the importance of prevention of cardiovascular disease in childhood. Lifestyle modification with appropriate diet and exercise can reduce cardiovascular risk in children," said lead author Daniel L. Preud'Homme, M.D., associate professor of medicine at the Wright State University School of Medicine and director of the lipid clinic at The Children's Medical Center, both in Dayton, Ohio.

RMND1 gene mutations responsible for severe neurodegenerative disorders

Scientists at the Montreal Neurological Institute and Hospital - The Neuro, McGill University working with a team at Oxford University have uncovered the genetic defect underlying a group of rare genetic disorders.

Latin America attempts to increase access to emergency contraception

Governments across Latin America are attempting to increase access to emergency contraception - which can prevent pregnancy if taken within 72 hours of sexual intercourse - despite "stiff resistance" from the Roman Catholic Church, Reuters reports.

Read more Medical News

› Verified 9 days ago


NPI Number1245387372
Organization NameCHRIS JENSEN LLC
Doing Business AsCHRIS JENSEN HEALTH & REHABILITION CENTER
Address2501 Rice Lake Rd, Duluth, MN 55811
Phone Number218-625-6411

News Archive

FDA approves BENLYSTA for active, autoantibody-positive systemic lupus erythematosus

Human Genome Sciences, Inc. and GlaxoSmithKline PLC today announced that the U.S. Food and Drug Administration has approved BENLYSTA® (belimumab) for the treatment of adult patients with active, autoantibody-positive systemic lupus erythematosus (SLE) who are receiving standard therapy.

Phase II study of TroVax vaccine in patients with metastatic colorectal cancer

A therapeutic cancer vaccine has shown effectiveness when given alongside chemotherapy to patients with metastatic colorectal cancer in a phase II trial, according to researchers at Oxford BioMedica (UK) Ltd.

Severely obese children have lipoprotein profiles that signal early risk of cardiovascular disease and the metabolic syndrome

"The message is urgent about the importance of prevention of cardiovascular disease in childhood. Lifestyle modification with appropriate diet and exercise can reduce cardiovascular risk in children," said lead author Daniel L. Preud'Homme, M.D., associate professor of medicine at the Wright State University School of Medicine and director of the lipid clinic at The Children's Medical Center, both in Dayton, Ohio.

RMND1 gene mutations responsible for severe neurodegenerative disorders

Scientists at the Montreal Neurological Institute and Hospital - The Neuro, McGill University working with a team at Oxford University have uncovered the genetic defect underlying a group of rare genetic disorders.

Latin America attempts to increase access to emergency contraception

Governments across Latin America are attempting to increase access to emergency contraception - which can prevent pregnancy if taken within 72 hours of sexual intercourse - despite "stiff resistance" from the Roman Catholic Church, Reuters reports.

Read more Medical News

› Verified 9 days ago


NPI Number1306588538
Organization NameJENSEN HEALTH LLC
Address2501 Rice Lake Road, Duluth, MN 55811
Phone Number218-625-6400

News Archive

FDA approves BENLYSTA for active, autoantibody-positive systemic lupus erythematosus

Human Genome Sciences, Inc. and GlaxoSmithKline PLC today announced that the U.S. Food and Drug Administration has approved BENLYSTA® (belimumab) for the treatment of adult patients with active, autoantibody-positive systemic lupus erythematosus (SLE) who are receiving standard therapy.

Phase II study of TroVax vaccine in patients with metastatic colorectal cancer

A therapeutic cancer vaccine has shown effectiveness when given alongside chemotherapy to patients with metastatic colorectal cancer in a phase II trial, according to researchers at Oxford BioMedica (UK) Ltd.

Severely obese children have lipoprotein profiles that signal early risk of cardiovascular disease and the metabolic syndrome

"The message is urgent about the importance of prevention of cardiovascular disease in childhood. Lifestyle modification with appropriate diet and exercise can reduce cardiovascular risk in children," said lead author Daniel L. Preud'Homme, M.D., associate professor of medicine at the Wright State University School of Medicine and director of the lipid clinic at The Children's Medical Center, both in Dayton, Ohio.

RMND1 gene mutations responsible for severe neurodegenerative disorders

Scientists at the Montreal Neurological Institute and Hospital - The Neuro, McGill University working with a team at Oxford University have uncovered the genetic defect underlying a group of rare genetic disorders.

Latin America attempts to increase access to emergency contraception

Governments across Latin America are attempting to increase access to emergency contraception - which can prevent pregnancy if taken within 72 hours of sexual intercourse - despite "stiff resistance" from the Roman Catholic Church, Reuters reports.

Read more Medical News

› Verified 9 days ago


NPI Number1497093272
Address2501 Rice Lake Rd, Duluth, MN 55811
Phone Number218-625-6444

News Archive

FDA approves BENLYSTA for active, autoantibody-positive systemic lupus erythematosus

Human Genome Sciences, Inc. and GlaxoSmithKline PLC today announced that the U.S. Food and Drug Administration has approved BENLYSTA® (belimumab) for the treatment of adult patients with active, autoantibody-positive systemic lupus erythematosus (SLE) who are receiving standard therapy.

Phase II study of TroVax vaccine in patients with metastatic colorectal cancer

A therapeutic cancer vaccine has shown effectiveness when given alongside chemotherapy to patients with metastatic colorectal cancer in a phase II trial, according to researchers at Oxford BioMedica (UK) Ltd.

Severely obese children have lipoprotein profiles that signal early risk of cardiovascular disease and the metabolic syndrome

"The message is urgent about the importance of prevention of cardiovascular disease in childhood. Lifestyle modification with appropriate diet and exercise can reduce cardiovascular risk in children," said lead author Daniel L. Preud'Homme, M.D., associate professor of medicine at the Wright State University School of Medicine and director of the lipid clinic at The Children's Medical Center, both in Dayton, Ohio.

RMND1 gene mutations responsible for severe neurodegenerative disorders

Scientists at the Montreal Neurological Institute and Hospital - The Neuro, McGill University working with a team at Oxford University have uncovered the genetic defect underlying a group of rare genetic disorders.

Latin America attempts to increase access to emergency contraception

Governments across Latin America are attempting to increase access to emergency contraception - which can prevent pregnancy if taken within 72 hours of sexual intercourse - despite "stiff resistance" from the Roman Catholic Church, Reuters reports.

Read more Medical News

› Verified 9 days ago

Quality Ratings:

Nursing homes vary in the quality of care and services they provide to their residents. The below quality ratings for Chris Jensen Health & Rehabilitation Center are calculated from three sources - health inspection results, staffing data, and quality measure data. This information gives you an indication of the care Chris Jensen Health & Rehabilitation Center give to their patients.
Ratings from Surveys (Inspections):
Ratings from Quality Measures:
Ratings from Staffing Data:
Overall Rating:

News Archive

FDA approves BENLYSTA for active, autoantibody-positive systemic lupus erythematosus

Human Genome Sciences, Inc. and GlaxoSmithKline PLC today announced that the U.S. Food and Drug Administration has approved BENLYSTA® (belimumab) for the treatment of adult patients with active, autoantibody-positive systemic lupus erythematosus (SLE) who are receiving standard therapy.

Phase II study of TroVax vaccine in patients with metastatic colorectal cancer

A therapeutic cancer vaccine has shown effectiveness when given alongside chemotherapy to patients with metastatic colorectal cancer in a phase II trial, according to researchers at Oxford BioMedica (UK) Ltd.

Severely obese children have lipoprotein profiles that signal early risk of cardiovascular disease and the metabolic syndrome

"The message is urgent about the importance of prevention of cardiovascular disease in childhood. Lifestyle modification with appropriate diet and exercise can reduce cardiovascular risk in children," said lead author Daniel L. Preud'Homme, M.D., associate professor of medicine at the Wright State University School of Medicine and director of the lipid clinic at The Children's Medical Center, both in Dayton, Ohio.

RMND1 gene mutations responsible for severe neurodegenerative disorders

Scientists at the Montreal Neurological Institute and Hospital - The Neuro, McGill University working with a team at Oxford University have uncovered the genetic defect underlying a group of rare genetic disorders.

Latin America attempts to increase access to emergency contraception

Governments across Latin America are attempting to increase access to emergency contraception - which can prevent pregnancy if taken within 72 hours of sexual intercourse - despite "stiff resistance" from the Roman Catholic Church, Reuters reports.

Read more Medical News

› Verified 9 days ago

Complaints, Fines and Penalties:

Number of Facility Reported Incidents0
Number of Substantiated Complaints0
Number of Fines3
Total Amount of Fines in Dollars$51960
Number of Payment Denials2
Total Number of Penalties5

Patients' Stay Experience:

The resident survey data of Chris Jensen Health & Rehabilitation Center is compared against the national average with the color code indicators: Better than National Average Worse than National Average

Experience MeasureProviderNational Avg.
Percentage of long-stay residents whose need for help with daily activities has increased21.5814.46
Percentage of long-stay residents who lose too much weight15.925.51
Percentage of low risk long-stay residents who lose control of their bowels or bladder53.948.41
Percentage of long-stay residents with a catheter inserted and left in their bladder5.11.79
Percentage of long-stay residents with a urinary tract infection3.732.65
Percentage of long-stay residents who have depressive symptoms1.75.05
Percentage of long-stay residents who were physically restrained00.23
Percentage of long-stay residents experiencing one or more falls with major injury5.883.36
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine89.5493.87
Percentage of long-stay residents who received an antipsychotic medication26.7314.2
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine74.0383.88
Percentage of short-stay residents who newly received an antipsychotic medication3.371.79
Percentage of long-stay residents whose ability to move independently worsened32.617.09
Percentage of long-stay residents who received an antianxiety or hypnotic medication13.1119.7
Percentage of high risk long-stay residents with pressure ulcers6.027.32
Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine92.5995.98
Percentage of short-stay residents who made improvements in function72.6367.99
Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine59.0582.93

News Archive

FDA approves BENLYSTA for active, autoantibody-positive systemic lupus erythematosus

Human Genome Sciences, Inc. and GlaxoSmithKline PLC today announced that the U.S. Food and Drug Administration has approved BENLYSTA® (belimumab) for the treatment of adult patients with active, autoantibody-positive systemic lupus erythematosus (SLE) who are receiving standard therapy.

Phase II study of TroVax vaccine in patients with metastatic colorectal cancer

A therapeutic cancer vaccine has shown effectiveness when given alongside chemotherapy to patients with metastatic colorectal cancer in a phase II trial, according to researchers at Oxford BioMedica (UK) Ltd.

Severely obese children have lipoprotein profiles that signal early risk of cardiovascular disease and the metabolic syndrome

"The message is urgent about the importance of prevention of cardiovascular disease in childhood. Lifestyle modification with appropriate diet and exercise can reduce cardiovascular risk in children," said lead author Daniel L. Preud'Homme, M.D., associate professor of medicine at the Wright State University School of Medicine and director of the lipid clinic at The Children's Medical Center, both in Dayton, Ohio.

RMND1 gene mutations responsible for severe neurodegenerative disorders

Scientists at the Montreal Neurological Institute and Hospital - The Neuro, McGill University working with a team at Oxford University have uncovered the genetic defect underlying a group of rare genetic disorders.

Latin America attempts to increase access to emergency contraception

Governments across Latin America are attempting to increase access to emergency contraception - which can prevent pregnancy if taken within 72 hours of sexual intercourse - despite "stiff resistance" from the Roman Catholic Church, Reuters reports.

Read more News

› Verified 9 days ago


Nursing Homes in Duluth, MN

Ecumen Lakeshore
Location: 4002 London Road, Duluth, Minnesota 55804
Phone: (218) 625-7100    
Bayshore Residence & Rehab Ctr
Location: 1601 St Louis Avenue, Duluth, Minnesota 55802
Phone: (218) 727-8651    
Benedictine Health Center
Location: 935 Kenwood Avenue, Duluth, Minnesota 55811
Phone: (218) 522-8900    
Franciscan Health Center
Location: 3910 Minnesota Avenue, Duluth, Minnesota 55802
Phone: (218) 727-8933    
Chris Jensen Health & Rehabilitation Center
Location: 2501 Rice Lake Road, Duluth, Minnesota 55811
Phone: (218) 625-6400    
Viewcrest Health Center
Location: 3111 Church Street, Duluth, Minnesota 55811
Phone: (218) 727-8801    

Nursing Home

A nursing home (also called skilled nursing facility) is a facility or distinct part of an institution whose primary function is to provide medical, continuous nursing, and other health and social services to patients who are not in an acute phase of illness requiring services in a hospital, but who require primary restorative or skilled nursing services on an inpatient basis above the level of intermediate or custodial care in order to reach a degree of body functioning to permit self care in essential daily living.

A skilled nursing facility (SNF) may be a freestanding facility or part of a hospital that has been certified by Medicare to admit patients requiring subacute care and rehabilitation.

Nursing Home Compare

Nursing Home Compare allows consumers to compare information about nursing homes. It contains quality of care and staffing information for all 15,000 plus Medicare- and Medicaid-participating nursing homes.

Note: Nursing homes aren't included on Nursing Home Compare if they aren't Medicare or Medicaid certified. These Nursing Homes can be licensed by the state.

Information on Nursing Home Compare isn't an endorsement or advertisement for any nursing home and should be considered carefully. Use it with other information you gather about nursing homes facilities. Talk to your doctor or other health care provider about the information on Nursing Home Compare.

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.